Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors

被引：1
|
作者：
Alcazer, Vincent [1 ,2 ]
de Latour, Regis Peffault [3 ,4 ]
Ader, Florence [5 ,6 ]
Labussiere-Wallet, Helene [1 ]
机构：
[1] Hosp Civils Lyon, Dept Hematol Clin, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France
[2] Ctr Rech Cancerol Lyon, Inserm U1052, CNRS 5286, F-69008 Lyon, France
[3] Hop St Louis, AP HP, Serv Hematol Greffe, F-75006 Paris, France
[4] Univ Paris Diderot, F-75007 Paris, France
[5] Hosp Civils Lyon, Serv Malad Infect, F-69004 Lyon, France
[6] Ctr Int Rech Infectiol, Inserm U1111, CNRS 5308, F-69008 Lyon, France
来源：
BULLETIN DU CANCER | 2019年 / 106卷 / 06期
关键词：
Allogeneic hematopoietic; stem cell transplantation; Graft failure; Rejection; Infections; ANTI-HLA ANTIBODIES; BONE-MARROW-TRANSPLANTATION; PERIPHERAL-BLOOD; RETROSPECTIVE ANALYSIS; FRANCOPHONE SOCIETY; APLASTIC-ANEMIA; DONOR; IMPACT; OUTCOMES; ENGRAFTMENT;
D O I：
10.1016/j.bulcan.2019.03.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Allogeneic hematopoietic stem cell transplantation is the only curative therapy for numerous malignant and non-malignant haematological diseases. A sustained engraftment of the donor stem cells is essential for transplant success and overall outcome. Graft failure is a rare but severe event after allogeneic hematopoietic stem cell transplantation. While different risk factors such as underlying disease, graft source or HLA matching have been found to be consistently associated with graft failure, other factors such as ABO mismatch graft-versus-host disease prophylaxis or infections, particularly viral reactivations, are more controversial. In this article, we review the different factors associated with graft failure.
引用
收藏
页码：574 / 583
页数：10
相关论文
共 50 条
  • [41] Risk Factors for Graft Failure and Survival after Reduced Intensity (RIC) Conditioning Allogeneic Hematopoietic Cell Transplantation (HUT) for Myelofibrosis
    Glotzbecker, Brett
    Kim, Haesook T.
    Cutler, Corey S.
    Koreth, John
    Armand, Philippe
    Nikiforow, Sarah
    Antin, Joseph H.
    Soiffer, Robert J.
    Alyea, Edwin P., III
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S34 - S34
  • [42] Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Xiao, Yang
    Song, Jiayin
    Jiang, Zujun
    Li, Yonghua
    Gao, Yang
    Xu, Wenning
    Lu, Ziyuan
    Wang, Yaochun
    Xiao, Haowen
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (06): : 652 - 657
  • [43] Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation
    Kubo, Hiroyuki
    Imataki, Osamu
    Fukumoto, Tetsuya
    Oku, Maki
    Ishida, Tomoya
    Kubo, Yukiko Hamasaki
    Kida, Jun-ichiro
    Uemura, Makiko
    Fujita, Haruyuki
    Ohno, Hirofumi
    Ide, Makoto
    Ohnishi, Hiroaki
    Kadowaki, Norimitsu
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 949.e1 - 949.e8
  • [44] Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival
    Spring, Laura
    Li, Shuli
    Soiffer, Robert J.
    Antin, Joseph H.
    Alyea, Edwin P., III
    Glotzbecker, Brett
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 509 - 516
  • [45] Prevalence, Risk Factors, and Outcomes of Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Bertelli, Luca
    Cazzato, Salvatore
    Belotti, Tamara
    Prete, Arcangelo
    Ricci, Giampaolo
    Pession, Andrea
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2017, 30 (02) : 113 - 115
  • [46] PREVALENCE, RISK FACTORS AND OUTCOMES OF BRONCHIOLITIS OBLITERANS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Bertelli, L.
    Martoni, A.
    Bardasi, G.
    Massaccesi, E.
    Zama, D.
    Morello, W.
    Cazzato, S.
    Masetti, R.
    Rondelli, R.
    Prete, A.
    Pession, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S258 - S258
  • [47] Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
    Uderzo, Cornelio
    Bonanomi, Sonia
    Busca, Alessandro
    Renoldi, Mila
    Ferrari, Pierantonio
    Iacobelli, Massimo
    Morreale, Giuseppe
    Lanino, Edoardo
    Annaloro, Claudio
    Della Volpe, Aldo
    Alessandrino, Paolo
    Longoni, Daniela
    Locatelli, Franco
    Sangalli, Haidi
    Rovelli, Attilio
    TRANSPLANTATION, 2006, 82 (05) : 638 - 644
  • [48] Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
    Alchalby, H.
    Yunus, D-R
    Zabelina, T.
    Ayuk, F.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1223 - 1227
  • [49] THE INCIDENCE, RISK FACTORS AND OUTCOME OF POOR GRAFT FUNCTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Sun, Y.
    Xu, L.
    Liu, D.
    Liu, K.
    Huang, X.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S478 - S478
  • [50] Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
    H Alchalby
    D-R Yunus
    T Zabelina
    F Ayuk
    N Kröger
    Bone Marrow Transplantation, 2016, 51 : 1223 - 1227
12345